Company / Return on Assets (ROA)
Bristol Myers Squibb Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
7.8%
FY2025
5-year range
-9.7% / 7.8%
FY2021-FY2025
Trend
+181.1%
vs FY2024
Sector context
#32 of 213
Health Care
What the data says
Bristol Myers Squibb's return on assets (roa) of 7.8% is higher than 85% of companies in the Health Care sector (FY2025). Return on Assets (ROA) has fluctuated over the past 10 years, ranging from -9.7% in FY2024 to 13.5% in FY2018.
Based on SEC 10-K filings.
7.8% in FY2025 with a 5-year CAGR of +15.4%. Top quartile in the Health Care sector.
Improved from 7.3% to 7.8% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +17.1pp
- 5-Year Change
- +15.4pp
- 10-Year Change
- -
Sector benchmark
+132.4% above sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 181.1% year-over-year.
- Currently 32.0pp above the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2018.
- Lowest return on assets (roa) in the period was in FY2024.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 0.85 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 32.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 7.8% | +181.1% |
| FY2024 | -9.7% | -231.4% |
| FY2023 | 7.3% | +178.9% |
| FY2022 | -9.3% | -395.6% |
| FY2021 | 3.1% | +141.4% |
| FY2020 | -7.6% | -363.3% |
| FY2019 | 2.9% | -78.5% |
| FY2018 | 13.5% | +340.2% |
| FY2017 | 3.1% | -51.3% |
| FY2016 | 6.3% | -17.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026